The pneumococcus, a type of bacteria in the Streptococcus family (Streptococcus pneumoniae), is responsible for several types of diseases in adults and in children. In developing countries, pneumococcus is linked to high infant and child mortality rates. Even in more industrialized nations, pneumococcal diseases are common in adults and children. These diseases can lead to severe illness and even death, despite being preventable in many cases. The April 12, 2006, issue of JAMA includes an article about pneumococcal diseases and the beneficial effect of pneumococcal vaccination in infants and children.
Meningitis (infection of the covering membranes of the brain and spinal cord)
Pneumonia (infection of the lungs)
Otitis media (middle ear infection)
Sinusitis (infection of the sinus cavities behind the face)
Bacteremia (bacteria in the bloodstream)
Sepsis (a serious bloodstream infection that can be fatal)
Meningitis can lead to permanent neurological damage or death. In adults and older children, it presents with fever, a stiff neck, fatigue, and headache. In infants, these signs may be absent, and the infant may only display fussiness, lethargy, and inability to feed. Individuals with pneumonia usually have shortness of breath, high fever, a cough, fatigue, and chest pains. Meningitis and sepsis are the most life-threatening pneumococcal diseases. Individuals with meningitis or sepsis must receive rapid diagnosis and treatment to prevent severe multiple organ failure and death.
Early diagnosis of pneumococcal infection is crucial to receiving proper antibiotic treatment. Some strains of pneumococcus have developed resistance to commonly used antibiotics. Laboratory testing is needed to determine proper therapy. Supportive therapy such as oxygen, intravenous fluids, surgical drainage, or even life support in an intensive care unit may be required in severe cases of pneumococcal infection.
Young children (aged 2 months to 24 months) should receive a special type of vaccine called the pneumococcal conjugate vaccine against pneumococcus. It is specifically formulated for effectiveness in infants and younger children.
Any person who has had a splenectomy (removal of the spleen) should have the pneumococcal vaccine.
The polysaccharide pneumococcal vaccine should be considered for individuals older than 65 years and for those older than 2 years who have chronic diseases.
Frequent handwashing is important for preventing the spread of pneumococcal diseases, as well as other bacterial and viral infections.
Grahic Jump Location
National Institute of Allergy and Infectious Diseaseshttp://www.niaid.nih.gov
Centers for Disease Control and Preventionhttp://www.cdc.gov
American Academy of Pediatricshttp://www.aap.org
To find this and previous JAMA Patient Pages, go to the Patient Page Index on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on meningitis in children was published in the April 28, 1999, issue; one on diagnosing and treating pneumonia was published in the February 9, 2000, issue; and one on fever in infants was published in the March 10, 2004, issue.
Sources: National Institute of Allergy and Infectious Diseases; Centers for Disease Control and Prevention; American Academy of Family Physicians; American Academy of Pediatrics
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724
TOPIC: INFECTIOUS DISEASES
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.